Article info

Download PDFPDF

Extended report
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

Authors

  • J B Lilleker Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, UK PubMed articlesGoogle scholar articles
  • A Rietveld Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • S R Pye Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • K Mariampillai Department of Internal Medicine and Clinical Immunology, La Pitié-Salpêtrière Hospital, AP-HP, INSERM U974, UPMC, Paris, France PubMed articlesGoogle scholar articles
  • O Benveniste Department of Internal Medicine and Clinical Immunology, La Pitié-Salpêtrière Hospital, AP-HP, INSERM U974, UPMC, Paris, France PubMed articlesGoogle scholar articles
  • M T J Peeters Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • J A L Miller Department of Neurology, Royal Victoria Hospitals, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK PubMed articlesGoogle scholar articles
  • M G Hanna MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK PubMed articlesGoogle scholar articles
  • P M Machado MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK Centre for Rheumatology Research, University College London, London, UK PubMed articlesGoogle scholar articles
  • M J Parton MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK PubMed articlesGoogle scholar articles
  • K R Gheorghe Unit of Rheumatology, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • U A Badrising Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • I E Lundberg Unit of Rheumatology, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • S Sacconi Peripheral Nervous System, Muscle and ALS Department, Université Côté Azure (UCA), Nice University Hospital, Nice, France PubMed articlesGoogle scholar articles
  • M K Herbert Department of Biomolecular Chemistry, Radboud Institute for Molecular Life Sciences and Institute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • N J McHugh Royal National Hospital for Rheumatic Diseases and Department of Pharmacy and Pharmacology, University of Bath, Bath, UK PubMed articlesGoogle scholar articles
  • B R F Lecky The Walton Centre NHS Foundation Trust, Fazakerley, Liverpool, UK PubMed articlesGoogle scholar articles
  • C Brierley Department of Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK PubMed articlesGoogle scholar articles
  • D Hilton-Jones Nuffield Department of Clinical Neurosciences, Oxford University Hospitals, Oxford, UK PubMed articlesGoogle scholar articles
  • J A Lamb Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • M E Roberts Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, UK PubMed articlesGoogle scholar articles
  • R G Cooper Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK MRC-ARUK Institute for Ageing and Chronic Disease, University of Liverpool, Liverpool, UK Rheumatology Department, Salford Royal NHS Foundation Trust, Salford, UK PubMed articlesGoogle scholar articles
  • C G J Saris Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • G J M Pruijn Department of Biomolecular Chemistry, Radboud Institute for Molecular Life Sciences and Institute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • H Chinoy Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK Rheumatology Department, Salford Royal NHS Foundation Trust, Salford, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • B G M van Engelen Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr J B Lilleker, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK; james.lilleker{at}manchester.ac.uk
View Full Text

Citation

Lilleker JB, Rietveld A, Pye SR On behalf of all UKMYONET contributors, et al
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

Publication history

  • Received July 29, 2016
  • Revised October 7, 2016
  • Accepted November 5, 2016
  • First published January 25, 2017.
Online issue publication 
April 06, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.